Login

Krux Analytics optimizes drilling activities and costs to maximize meters drilled in drill programs.|Jody Conrad Chief Executive Officer of Krux Analytics 00:10:00

Share On Facebook Share On Twitter

Jody Conrad, Founder & CEO, Krux Analytics

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Amex Exploration: Recent Gold Discovery in Quebec
00:10:00
Lojas Quero-Quero Unveils "Infinite Store" with 20,000 Construction Items Online, Says CEO Peter Furukawa | Peter Furukawa, CEO, Lojas Quero-Quero SA.
00:10:00
Q&A with Neal Barclay, CEO of Meridian Energy, on European politics' impact discussed in Craigs Investment Partners' Weekly Update.
00:10:00
Alaska Black Institucional and Alaska Black BDR Funds Overview
00:10:00
ZIDA CEO Tafadzwa Chinamo Addresses Mine Africa Inc Conference in Toronto
00:10:00
Aim to help founders across all stages to navigate and scale-up in the complex European business|Pascal Cagni,Founder & CEO,C4 Ventures
00:10:00
Orion Minerals' Strategic Development Plans Unveiled at One-to-One Mining Conference in Cape Town
00:00:00
GenSight Biologics - Magali Taiel Chief Medical Officer, Gensight Biologics
00:10:00
Farid Basir, Chief Human Capital Officer at Telekom Malaysia, will speak at Asia's largest HR and Work Tech Conference in February.
00:10:00
Christian Jansson, CEO of Godsinlösen Nordics, Discusses Upcoming First North Listing | Christian Jansson, CEO , Godsinlösen Nordics AB.
00:10:00
From IT Entrepreneurship to Real Estate: A Journey of Innovation and Adaptation | Falk Raudies , CEO, FCR Immobilien AG.
00:00:00
Nordic Congress 2018: Herantis Pharma CEO Pekka Simula - Pekka Simula, CEO, Herantis Pharma

© 2017 - Neuhu+